Insiders · CLDX

CLDX insider transactions

Celldex Therapeutics Inc. (CLDX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for CLDX

• 18d
  SEC Form 4 filed by SVP & Chief Commercial Officer Lawver Teri L

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 18d
  SEC Form 4 filed by SVP & GENERAL COUNSEL Jimenez Freddy A.

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 18d
  SEC Form 4 filed by SVP, CHIEF MEDICAL OFFICER Young Diane C.

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 18d
  SEC Form 4 filed by SVP OF REGULATORY AFFAIRS Heath-Chiozzi Margo

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 18d
  SEC Form 4 filed by SVP AND CFO Martin Samuel Bates

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 18d
  SEC Form 4 filed by SVP OF CORP AFFAIRS & ADMIN. Cavanaugh Sarah

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 18d
  SEC Form 4 filed by SR. VP & CPDO Crowley Elizabeth

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 18d
  SEC Form 4 filed by SR. VP & CBO Pepin Ronald

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 18d
  SEC Form 4 filed by EXECUTIVE VP & CSO Keler Tibor

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 18d
  SEC Form 4 filed by PRESIDENT & CEO Marucci Anthony S

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 18d
  SEC Form 4 filed by Director Torres Denice

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 18d
  SEC Form 4 filed by Director Jain Rita

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 18d
  SEC Form 4 filed by Director Neil Garry Arthur

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 18d
  SEC Form 4 filed by Director Cohen Cheryl

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 18d
  SEC Form 4 filed by Director Brownlie Keith L

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 18d
  SEC Form 4 filed by Director Marino James J

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 18d
  SEC Form 4 filed by Director Conrad Herbert J

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 18d
  SEC Form 4 filed by Director Penner Harry Jr

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 192d
  SVP AND CFO Martin Samuel Bates exercised 4,817 shares at a strike of $10.38, increasing direct ownership by 17% to 32,942 units (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 212d
  SR. VP & CBO Pepin Ronald exercised 19,333 shares at a strike of $5.47, increasing direct ownership by 2,530% to 20,097 units (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 221d
  SVP & GENERAL COUNSEL Jimenez Freddy A. sold $121,210 worth of shares (4,166 units at $29.09), decreasing direct ownership by 12% to 30,796 units (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 242d
  Former Officer Wright Richard M. sold $1,183,177 worth of shares (49,298 units at $24.00) and exercised 49,298 shares at a strike of $14.06 (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 247d
  SEC Form 4 filed by SVP & Chief Commercial Officer Lawver Teri L

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 247d
  SEC Form 3 filed by new insider Lawver Teri L

  3 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 336d
  SVP & GENERAL COUNSEL Jimenez Freddy A. sold $19,096 worth of shares (771 units at $24.77), decreasing direct ownership by 2% to 34,962 units (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 403d
  SEC Form 4 filed by SVP OF CORP AFFAIRS & ADMIN. Cavanaugh Sarah

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 403d
  SEC Form 4 filed by SR. VP & CPDO Crowley Elizabeth

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 403d
  SEC Form 4 filed by SVP OF REGULATORY AFFAIRS Heath-Chiozzi Margo

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 403d
  SEC Form 4 filed by SVP & GENERAL COUNSEL Jimenez Freddy A.

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 403d
  SEC Form 4 filed by SVP AND CFO Martin Samuel Bates

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 403d
  SEC Form 4 filed by SR. VP & CBO Pepin Ronald

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 403d
  SEC Form 4 filed by SVP, CHIEF MEDICAL OFFICER Young Diane C.

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 403d
  SEC Form 4 filed by EXECUTIVE VP & CSO Keler Tibor

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 403d
  SEC Form 4 filed by PRESIDENT & CEO Marucci Anthony S

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 403d
  SEC Form 4 filed by Director Torres Denice

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 403d
  SEC Form 4 filed by Director Jain Rita

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 403d
  SEC Form 4 filed by Director Neil Garry Arthur

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 403d
  SEC Form 4 filed by Director Penner Harry Jr

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 403d
  SEC Form 4 filed by Director Conrad Herbert J

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 403d
  SEC Form 4 filed by Director Marino James J

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 403d
  SEC Form 4 filed by Director Brownlie Keith L

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 403d
  SEC Form 4 filed by Director Cohen Cheryl

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 406d
  SEC Form 3 filed by new insider Torres Denice

  3 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 604d
  Director Marino James J gifted 10,500 shares, decreasing direct ownership by 83% to 2,204 units (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 612d
  PRESIDENT & CEO Marucci Anthony S bought $308,430 worth of shares (11,500 units at $26.82), increasing direct ownership by 40% to 40,284 units (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 759d
  SVP AND CFO Martin Samuel Bates exercised 20,169 shares at a strike of $10.16 and sold $608,315 worth of shares (17,172 units at $35.42), increasing direct ownership by 12% to 28,125 units (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 759d
  SR. VP & CPDO Crowley Elizabeth exercised 30,000 shares at a strike of $10.38 and sold $1,045,962 worth of shares (30,000 units at $34.87) (SEC Form 4)

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 760d
  SEC Form 4 filed by SVP & GENERAL COUNSEL Jimenez Freddy A.

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 760d
  SEC Form 4 filed by SVP, CHIEF MEDICAL OFFICER Young Diane C.

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 760d
  SEC Form 4 filed by SVP OF REGULATORY AFFAIRS Heath-Chiozzi Margo

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 760d
  SEC Form 4 filed by SVP OF CORP AFFAIRS & ADMIN. Cavanaugh Sarah

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 760d
  SEC Form 4 filed by SR. VP & CPDO Crowley Elizabeth

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 760d
  SEC Form 4 filed by SR. VP & CCO Wright Richard M.

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 760d
  SEC Form 4 filed by SR. VP & CBO Pepin Ronald

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 760d
  SEC Form 4 filed by SVP AND CFO Martin Samuel Bates

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 760d
  SEC Form 4 filed by EXECUTIVE VP & CSO Keler Tibor

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 760d
  SEC Form 4 filed by PRESIDENT & CEO Marucci Anthony S

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 760d
  SEC Form 4 filed by Director Jain Rita

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 760d
  SEC Form 4 filed by Director Neil Garry Arthur

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)
• 760d
  SEC Form 4 filed by Director Cohen Cheryl

  4 - Celldex Therapeutics, Inc. (0000744218) (Issuer)